603676 Share Price Performance
CN¥11.68
2.12 (22.18%)
Price CN¥11.68
Share PriceCN¥11.68
Tibet Weixinkang Medicine Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
603676 Community Narratives
There are no narratives available yet.
Recent 603676 News & Updates
Tibet Weixinkang Medicine Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 30, 2025
- Earnings per share (EPS)
- 0.61
- Gross Margin
- 56.96%
- Net Profit Margin
- 21.19%
- Debt/Equity Ratio
- 0%
Tibet Weixinkang Medicine Co., Ltd. Competitors
Snowflake Analysis
About 603676
- Founded
- 2006
- Employees
- 689
- CEO
- WebsiteView website
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases, and other special fields. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2006 and is based in Lhasa, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 0.5%
- 3 Months: 17.0%
- 1 Year: 24.1%
- Year to Date: 26.2%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. As for the longer term, the market has risen 24% in the past 12 months. Earnings are forecast to grow by 27% annually. Market details ›